Artificial Intelligence-Based Chatbots for Promoting Health Behavioral Changes: Systematic Review
- PMID: 36826990
- PMCID: PMC10007007
- DOI: 10.2196/40789
Artificial Intelligence-Based Chatbots for Promoting Health Behavioral Changes: Systematic Review
Abstract
Background: Artificial intelligence (AI)-based chatbots can offer personalized, engaging, and on-demand health promotion interventions.
Objective: The aim of this systematic review was to evaluate the feasibility, efficacy, and intervention characteristics of AI chatbots for promoting health behavior change.
Methods: A comprehensive search was conducted in 7 bibliographic databases (PubMed, IEEE Xplore, ACM Digital Library, PsycINFO, Web of Science, Embase, and JMIR publications) for empirical articles published from 1980 to 2022 that evaluated the feasibility or efficacy of AI chatbots for behavior change. The screening, extraction, and analysis of the identified articles were performed by following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
Results: Of the 15 included studies, several demonstrated the high efficacy of AI chatbots in promoting healthy lifestyles (n=6, 40%), smoking cessation (n=4, 27%), treatment or medication adherence (n=2, 13%), and reduction in substance misuse (n=1, 7%). However, there were mixed results regarding feasibility, acceptability, and usability. Selected behavior change theories and expert consultation were used to develop the behavior change strategies of AI chatbots, including goal setting, monitoring, real-time reinforcement or feedback, and on-demand support. Real-time user-chatbot interaction data, such as user preferences and behavioral performance, were collected on the chatbot platform to identify ways of providing personalized services. The AI chatbots demonstrated potential for scalability by deployment through accessible devices and platforms (eg, smartphones and Facebook Messenger). The participants also reported that AI chatbots offered a nonjudgmental space for communicating sensitive information. However, the reported results need to be interpreted with caution because of the moderate to high risk of internal validity, insufficient description of AI techniques, and limitation for generalizability.
Conclusions: AI chatbots have demonstrated the efficacy of health behavior change interventions among large and diverse populations; however, future studies need to adopt robust randomized control trials to establish definitive conclusions.
Keywords: AI; acceptability; artificial intelligence; chatbot; efficacy; engagement; feasibility; health behavior change; intervention; mobile phone; usability.
©Abhishek Aggarwal, Cheuk Chi Tam, Dezhi Wu, Xiaoming Li, Shan Qiao. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 24.02.2023.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- Laranjo L, Dunn AG, Tong HL, Kocaballi AB, Chen J, Bashir R, Surian D, Gallego B, Magrabi F, Lau AY, Coiera E. Conversational agents in healthcare: a systematic review. J Am Med Inform Assoc. 2018 Sep 01;25(9):1248–58. doi: 10.1093/jamia/ocy072. https://europepmc.org/abstract/MED/30010941 5052181 - DOI - PMC - PubMed
-
- Oh YJ, Zhang J, Fang ML, Fukuoka Y. A systematic review of artificial intelligence chatbots for promoting physical activity, healthy diet, and weight loss. Int J Behav Nutr Phys Act. 2021 Dec 11;18(1):160. doi: 10.1186/s12966-021-01224-6. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01224-6 10.1186/s12966-021-01224-6 - DOI - DOI - PMC - PubMed
-
- Duarte A, Walker S, Littlewood E, Brabyn S, Hewitt C, Gilbody S, Palmer S. Cost-effectiveness of computerized cognitive-behavioural therapy for the treatment of depression in primary care: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. Psychol Med. 2017 Jul;47(10):1825–35. doi: 10.1017/S0033291717000289. https://eprints.whiterose.ac.uk/112960/ S0033291717000289 - DOI - PubMed
-
- Gilbody S, Brabyn S, Lovell K, Kessler D, Devlin T, Smith L, Araya R, Barkham M, Bower P, Cooper C, Knowles S, Littlewood E, Richards DA, Tallon D, White D, Worthy G, REEACT collaborative Telephone-supported computerised cognitive-behavioural therapy: REEACT-2 large-scale pragmatic randomised controlled trial. Br J Psychiatry. 2017 May;210(5):362–7. doi: 10.1192/bjp.bp.116.192435. https://core.ac.uk/reader/79608833?utm_source=linkout S0007125000281439 - DOI - PubMed
-
- Galvão Gomes da Silva J, Kavanagh DJ, Belpaeme T, Taylor L, Beeson K, Andrade J. Experiences of a motivational interview delivered by a robot: qualitative study. J Med Internet Res. 2018 May 03;20(5):e116. doi: 10.2196/jmir.7737. https://www.jmir.org/2018/5/e116/ v20i5e116 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
